ARIAD Pharmaceuticals, Inc.
(NASDAQ : ARIA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.25%80.040.9%$592.67m
CELGCelgene Corporation
-1.39%136.931.1%$550.67m
AMGNAmgen Inc.
-0.14%185.941.1%$449.23m
BIIBBiogen Inc.
0.20%345.171.2%$387.27m
REGNRegeneron Pharmaceuticals, Inc.
-1.34%436.612.7%$313.67m
ALNYAlnylam Pharmaceuticals, Inc
-1.90%116.4510.7%$251.45m
VRTXVertex Pharmaceuticals Incorporated
-0.37%154.481.9%$220.64m
INCYIncyte Corporation
-0.36%115.222.5%$207.21m
ALXNAlexion Pharmaceuticals, Inc.
-1.89%140.451.9%$178.59m
ILMNIllumina, Inc.
-0.23%206.003.5%$139.55m
EXELExelixis, Inc.
-1.91%27.766.5%$132.85m
CLVSClovis Oncology, Inc.
-2.44%79.3416.5%$121.64m
BLUEBluebird Bio, Inc.
-1.25%138.4517.3%$116.64m
SRPTSarepta Therapeutics, Inc.
-0.04%51.7016.9%$109.98m
BMRNBioMarin Pharmaceutical Inc.
-4.46%89.374.4%$98.88m

Company Profile

ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. Its products include Iclusig and Caregivers. The company was founded by Harvey J. Berger in April 1991 and is headquartered in Cambridge, MA.